Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theranostic company focused on advancing therapeutic solutions for sepsis and septic shock. The Company develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The Company also offers the Endotoxin Activity Assay (EAA), the diagnostic... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire 1 day ago

Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF

GlobeNewswire September 29, 2025

Spectral Medical Announces Publication of EDEN Observational Study

GlobeNewswire September 16, 2025

Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 - 9, 2025

GlobeNewswire September 8, 2025

Spectral Medical Receives US$3 Million From Vantive

GlobeNewswire August 25, 2025

Canadian Investment Regulatory Organization Trade Resumption - EDT

Canada NewsWire August 13, 2025

Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

GlobeNewswire August 12, 2025

Canadian Investment Regulatory Organization Trading Halt - EDT

Canada NewsWire August 12, 2025

Spectral Medical Announces Second Quarter and Provides Corporate Update

GlobeNewswire August 8, 2025

Spectral Medical Inc. Announces Filing of Base Shelf Prospectus

GlobeNewswire July 4, 2025

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

GlobeNewswire June 6, 2025

Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

GlobeNewswire May 16, 2025

Spectral Medical Announces First Quarter and Provides Corporate Update

GlobeNewswire May 9, 2025

Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive

GlobeNewswire May 7, 2025

Spectral Medical Completes Tigris Trial Enrollment

GlobeNewswire April 16, 2025

Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update

GlobeNewswire March 27, 2025

Spectral Medical Provides February Tigris Trial Update

GlobeNewswire March 3, 2025

Spectral Medical Provides January Tigris Trial Update

GlobeNewswire February 3, 2025

Spectral Medical Provides December Tigris Trial Update

GlobeNewswire January 6, 2025

Spectral Medical Provides November Tigris Trial Update

GlobeNewswire December 2, 2024